LabGenomics Co Ltd is a Korea-based company principally engaged in the provision of in diagnostic and testing services. The Company provides general diagnostic, sample analysis and various genetic molecular diagnostic such as prenatal malformation testing, cancer genetic testing, chromosome abnormality testing and personal genetic testing. The Company also provides in vitro diagnostic products such as deoxyribonucleic acid (DNA) kits, COVID kits, polymerase chain reaction (PCR) kits and others. In addition, the Company provides biosensor for point of care testing (POCT) and healthy food.

Employees

105

Sector

Healthcare Facilities & Services

Calendar

23/09 Significant Split/Dividend

More about the company

Quotes

Date	Price	Change	Volume
31/26/31	₩500.00	-10.55%	19,04,945
28/26/28	₩559.00	-6.99%	13,53,305
27/26/27	₩601.00	-0.99%	4,27,777
26/26/26	₩607.00	+1.00%	4,06,522

End-of-day quote Korea S.E.

More quotes

Net sales - Rate of surprise

Company calendar

End-of-day quote Korea S.E. 31/08/2026			5-day change	1st Jan Change
500.00 ^KRW	-10.55%		-16.81%	-72.39%

24/08	LabGenomics Co., Ltd.(KOSDAQ:A084650) dropped from S&P Global BMI Index	CI
15/06	Daewoong Bio and LabGenomics Collaborate to Introduce Blood-Based Alzheimer?s Disease Diagnostic Technology in Korea	CI

Market Cap	3.71TCr 2.76Cr 2.37Cr 2.23Cr 2.04Cr 3.81Cr 260.24Cr 3.82Cr 26Cr 10Cr 133.52Cr 10Cr 10Cr 430.14Cr	P/E 2024	-7.77x	P/E 2025	-2.09x
Enterprise Value	3.46TCr 2.57Cr 2.21Cr 2.08Cr 1.9Cr 3.55Cr 242.57Cr 3.56Cr 25Cr 9.54Cr 124.46Cr 9.65Cr 9.44Cr 400.94Cr	EV / Sales 2024	1.68x	EV / Sales 2025	1.5x
Free-Float	83.31%	Yield 2024 *	-	Yield 2025	-

24/08	LabGenomics Co., Ltd.(KOSDAQ:A084650) dropped from S&P Global BMI Index	CI
15/06	Daewoong Bio and LabGenomics Collaborate to Introduce Blood-Based Alzheimer?s Disease Diagnostic Technology in Korea	CI
20/05	LabGenomics Co., Ltd. announced that it has received KRW 20 billion in funding	CI
12/05	LabGenomics Co., Ltd. announced that it expects to receive KRW 20 billion in funding	CI
23/25/23	LabGenomics Appoints CEO	MT
24/23/24	LabGenomics USA LLC announced that it has received KRW 75.948 billion in funding from LabGenomics Co., Ltd.	CI
03/23/03	LabGenomics USA LLC announced that it expects to receive KRW 70 billion in funding from LabGenomics Co., Ltd.	CI
11/23/11	Abion Inc. announced that it expects to receive KRW 21 billion in funding from LabGenomics Co., Ltd., Atinum Investment Co., Ltd, NH Investment & Securities Co., Ltd., Investment and others	CI
10/23/10	N Citron, Inc. announced that it has received KRW 1.999999776 billion in funding from LabGenomics Co., Ltd.	CI
31/23/31	N Citron, Inc. announced that it expects to receive KRW 1.999999776 billion in funding from LabGenomics Co., Ltd.	CI
18/23/18	LabGenomics Co., Ltd. announced that it has received KRW 22.71198072 billion in funding	CI
20/22/20	LabGenomics Co., Ltd. announced that it expects to receive KRW 34.09367874 billion in funding	CI
19/22/19	LabGenomics Co., Ltd. announced that it expects to receive KRW 82.71198072 billion in funding from Luha Private Equity and another investor	CI

1 day	-10.55%
1 week	-16.81%
1 month	-13.49%
3 months	-44.26%
6 months	-65.59%
Current year	-72.39%

LabGenomics Co., Ltd. Share Price

Stocks

A084650

KR7084650001

Healthcare Facilities & Services

Valuation : LabGenomics Co., Ltd.

Chart: LabGenomics Co., Ltd.

Latest news : LabGenomics Co., Ltd.

Press Releases : LabGenomics Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors : LabGenomics Co., Ltd.

Latest insider transactions

Medical & Diagnostic Laboratories

Financials

Company Profile

Quotes

Net sales - Rate of surprise

1 week	499	558
1 month	499	1,019
Current year	499	1,983
1 year	499	2,545
3 years	499	6,440
5 years	499	7,000
10 years	499	9,633.33

Manager	Title	Age	Since
Jae-Hak Ryu CEO	Chief Executive Officer	50	23/06/2025
Mi-Seon Moon AUD	Comptroller/Controller/Auditor	42	31/03/2026

Director	Title	Age	Since
Yu-Chan Kim BRD	Director/Board Member	59	10/03/2023
Kyung-Deuk Park BRD	Director/Board Member	42	28/03/2024
Jong-Hoon Lee BRD	Director/Board Member	42	10/03/2023

Date	Insider	Type	Main position	Quantity	% Market Cap.
17/06/24	Jong-Hoon Lee	Buy	Chief Executive Officer	42,000	0.0566%
11/03/24	Gwang-jin Seong	Others		14,104	0.0190%
11/03/24	Gwang-jin Seong	Free		14,104	0.0190%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LABGENOMICS CO., LTD.	-10.55%	-16.81%	-77.53%	-91.36%	2.73Cr
NATERA, INC.	-0.61%	+0.03%	+95.95%	+449.17%	4.72TCr
LABCORP HOLDINGS INC.	-1.22%	-2.08%	+19.22%	+60.50%	2.69TCr
SONIC HEALTHCARE LIMITED	+1.24%	-2.79%	-14.07%	-39.32%	686.25Cr
RADNET, INC.	-0.50%	-0.10%	+3.09%	+139.35%	587.24Cr
DR. LAL PATHLABS LIMITED	-2.48%	-3.04%	+12.51%	+70.58%	340.23Cr
GENEDX HOLDINGS CORP.	-2.09%	-0.93%	-34.34%	+1,857.21%	260.62Cr
NEOGENOMICS, INC.	-0.43%	-3.63%	+115.82%	+22.59%	224.32Cr
FLEURY S.A.	+8.89%	+7.74%	+31.76%	+37.74%	214.06Cr
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	+0.45%	-4.51%	-11.62%	-55.16%	183.25Cr
Average	-0.74%	-2.39%	+14.08%	+245.13%	991.03Cr
Weighted average by Cap.	-0.55%	-2.18%	+52.75%	+287.56%

	2024	2025
Net sales	8.59TCr 6.38Cr 5.49Cr 5.16Cr 4.72Cr 8.82Cr 602.21Cr 8.85Cr 61Cr 24Cr 308.98Cr 24Cr 23Cr 995.38Cr	8.82TCr 6.55Cr 5.63Cr 5.3Cr 4.84Cr 9.06Cr 618.08Cr 9.08Cr 63Cr 24Cr 317.12Cr 25Cr 24Cr 1.02TCr
Net income	-2.38TCr -1.77Cr -1.52Cr -1.43Cr -1.31Cr -2.44Cr -166.83Cr -2.45Cr -17Cr -6.56Cr -86Cr -6.64Cr -6.49Cr -275.74Cr	-6.44TCr -4.78Cr -4.11Cr -3.87Cr -3.54Cr -6.61Cr -451.31Cr -6.63Cr -46Cr -18Cr -231.55Cr -18Cr -18Cr -745.96Cr
Net Debt	-4.07TCr -3.02Cr -2.6Cr -2.44Cr -2.23Cr -4.18Cr -285.07Cr -4.19Cr -29Cr -11Cr -146.26Cr -11Cr -11Cr -471.19Cr	-252Cr -18.71L -16.1L -15.15L -13.84L -25.89L -18Cr -25.96L -1.79Cr -69.47L -9.06Cr -70.27L -68.73L -29Cr